Histologic subtyping affecting outcome of triple negative breast cancer: a large Sardinian population-based analysis
F Sanges, M Floris, P Cossu-Rocca, MR Muroni, G Pira… - BMC cancer, 2020 - Springer
Abstract Background Triple Negative breast cancer (TNBC) includes a heterogeneous group
of tumors with different clinico-pathological features, molecular alterations and treatment …
of tumors with different clinico-pathological features, molecular alterations and treatment …
Hsa‐miR‐375 is differentially expressed during breast lobular neoplasia and promotes loss of mammary acinar polarity
O Giricz, PA Reynolds, A Ramnauth… - The Journal of …, 2012 - Wiley Online Library
Invasive lobular carcinoma (ILC) of the breast, characterized by loss of E‐cadherin
expression, accounts for 5–15% of invasive breast cancers and it is believed to arise via a …
expression, accounts for 5–15% of invasive breast cancers and it is believed to arise via a …
[HTML][HTML] Polymorphisms of ESR1, UGT1A1, HCN1, MAP3K1 and CYP2B6 are associated with the prognosis of hormone receptor-positive early breast cancer
SH Kuo, SY Yang, SL You, HC Lien, CH Lin, PH Lin… - Oncotarget, 2017 - ncbi.nlm.nih.gov
In this study, we investigated whether single nucleotide polymorphisms (SNPs) identified by
genome-wide association study (GWAS)(MAP3K1, FGFR2, TNRC9, HCN1, and 5p12), and …
genome-wide association study (GWAS)(MAP3K1, FGFR2, TNRC9, HCN1, and 5p12), and …
Prognostic value of endopredict in women with hormone receptor–positive, her2-negative invasive lobular breast cancer
Purpose: Invasive lobular carcinoma (ILC) accounts for approximately 5%–15% of all
invasive breast cancer cases. Most of the correlations between multigene assays and …
invasive breast cancer cases. Most of the correlations between multigene assays and …
Transcriptomic and genomic features of invasive lobular breast cancer
Abstract Accounting for 10–15% of all breast neoplasms, invasive lobular breast cancer
(ILC) is the second most common histological subtype of breast cancer after invasive ductal …
(ILC) is the second most common histological subtype of breast cancer after invasive ductal …
Thrombospondin-4 expression is activated during the stromal response to invasive breast cancer
AE McCart Reed, S Song, JR Kutasovic, LE Reid… - Virchows Archiv, 2013 - Springer
The thromobospondins are a family of extracellular glycoproteins that are activated during
tissue remodeling processes such as embryogenesis, wound healing and cancer …
tissue remodeling processes such as embryogenesis, wound healing and cancer …
Association of Body Mass Index With 21-Gene Recurrence Score Among Women With Estrogen Receptor–Positive, ERBB2–Negative Breast Cancer
J Lee, H Kim, SJ Bae, JH Ji, JW Lee, BH Son… - JAMA network …, 2022 - jamanetwork.com
Importance Body mass index (BMI) may affect the 21-gene recurrence score (RS) in patients
with ER-positive, ERBB2-negative breast cancer. If high BMI increases genomic risk in ER …
with ER-positive, ERBB2-negative breast cancer. If high BMI increases genomic risk in ER …
Prognostic utility of breast cancer index to stratify distant recurrence risk in invasive lobular carcinoma
R Nunes, T Sella, K Treuner, JM Atkinson, J Wong… - Clinical Cancer …, 2021 - AACR
Purpose: The prognostic utility of Breast Cancer Index (BCI) for risk assessment of overall (0–
10 years), early (0–5 years), and late (5–10 years) distant recurrence (DR) in hormone …
10 years), early (0–5 years), and late (5–10 years) distant recurrence (DR) in hormone …
Loss of E-cadherin induces IGF1R activation and reveals a targetable pathway in invasive lobular breast carcinoma
A Elangovan, J Hooda, L Savariau… - Molecular Cancer …, 2022 - AACR
No special-type breast cancer [NST; commonly known as invasive ductal carcinoma (IDC)]
and invasive lobular carcinoma (ILC) are the two major histological subtypes of breast …
and invasive lobular carcinoma (ILC) are the two major histological subtypes of breast …
Pleomorphic lobular carcinoma in situ of the breast: clinicopathological review of 47 cases
Aims Pleomorphic lobular carcinoma in situ (PLCIS) of the breast is a distinctive entity, but its
behaviour and management are unclear. The purpose of this study was to review a relatively …
behaviour and management are unclear. The purpose of this study was to review a relatively …